Walleye Capital
XRAY icon

Walleye Capital’s Dentsply Sirona XRAY Stock Holding History

Walleye Capital’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Sell
23,700
-2,900
-11% -$31.7K ﹤0.01% 3322
2026
Q1 		$309K Sell
26,600
-6,500
-20% -$81.1K ﹤0.01% 3046
2025
Q4 		$378K Buy
33,100
+21,900
+196% +$257K ﹤0.01% 3132
2025
Q3 		$142K Sell
11,200
-6,800
-38% -$98.7K ﹤0.01% 3525
2025
Q2 		$286K Buy
18,000
+7,400
+70% +$111K ﹤0.01% 3080
2025
Q1 		$158K Sell
10,600
-2,000
-16% -$35.4K ﹤0.01% 3411
2024
Q4 		$239K Sell
12,600
-19,400
-61% -$410K ﹤0.01% 3617
2024
Q3 		$866K Buy
+32,000
New +$817K ﹤0.01% 2803
2020
Q1 		– Sell
-23,400
Closed -$1.32M – 1766
2019
Q4 		$1.32M Buy
23,400
+13,700
+141% +$764K 0.09% 320
2019
Q3 		$517K Sell
9,700
-8,300
-46% -$446K 0.03% 735
2019
Q2 		$1.05M Sell
18,000
-6,900
-28% -$371K 0.12% 248
2019
Q1 		$1.24M Buy
+24,900
New +$1.1M 0.2% 116
2018
Q3 		$540K Buy
+14,300
New +$595K 0.25% 119

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Walleye Capital's XRAY Position: Q2 2026 in Review

Walleye Capital reduced its Dentsply Sirona (XRAY) stake by 9.3% in Q2 2026, selling an estimated $15K and leaving 13,429 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #3695.

Walleye Capital first reported a position in XRAY in Q1 2019 and has held it in 18 quarters since. The position peaked at $8.2M in Q4 2024. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Walleye Capital held 13,429 shares of Dentsply Sirona worth $142K as of Q2 2026.
  • Walleye Capital sold 1,378 Dentsply Sirona shares in Q2 2026, an estimated $15K.
  • Dentsply Sirona made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3695 holding.
  • Walleye Capital first reported a position in Dentsply Sirona in Q1 2019 and has held it in 18 quarters since.
  • Walleye Capital's Dentsply Sirona position peaked at $8.2M in Q4 2024.
  • 374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.